We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$143M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$19M
3
AGN
Allergan plc
AGN
+$15M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSW icon
2226
OneSpaWorld
OSW
$2.7B
$106K ﹤0.01%
+22,321
New +$121K
CCRD
2227
DELISTED
CoreCard
CCRD
$106K ﹤0.01%
3,124
– –
APT icon
2228
Alpha Pro Tech
APT
$54.8M
$106K ﹤0.01%
+6,013
New +$83K
RRBI icon
2229
Red River Bancshares
RRBI
$674M
$106K ﹤0.01%
2,422
– –
CIVB icon
2230
Civista Bancshares
CIVB
$597M
$106K ﹤0.01%
6,893
– –
CMRE icon
2231
Costamare
CMRE
$1.71B
$106K ﹤0.01%
19,016
– –
SPT icon
2232
Sprout Social
SPT
$579M
$105K ﹤0.01%
+3,903
New +$85.6K
RUBY
2233
DELISTED
Rubius Therapeutics, Inc
RUBY
$105K ﹤0.01%
+17,589
New +$104K
LPG icon
2234
Dorian LPG
LPG
$1.91B
$105K ﹤0.01%
13,589
– –
FDBC icon
2235
Fidelity D&D Bancorp
FDBC
$322M
$105K ﹤0.01%
2,174
+759
+54% +$30.4K
LIND icon
2236
Lindblad Expeditions
LIND
$2.24B
$104K ﹤0.01%
+13,535
New +$93.4K
MCF
2237
DELISTED
Contango Oil & Gas Co.
MCF
$104K ﹤0.01%
+45,497
New +$111K
UTI icon
2238
Universal Technical Institute
UTI
$1.41B
$104K ﹤0.01%
+14,961
New +$98.2K
TPB icon
2239
Turning Point Brands
TPB
$1.73B
$104K ﹤0.01%
+4,174
New +$95.8K
ICAD
2240
DELISTED
iCAD Inc
ICAD
$104K ﹤0.01%
+10,383
New +$112K
GRTS
2241
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$103K ﹤0.01%
15,554
+2,612
+20% +$17.6K
SCU
2242
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$103K ﹤0.01%
7,985
– –
PLYM
2243
DELISTED
Plymouth Industrial REIT
PLYM
$103K ﹤0.01%
+8,052
New +$107K
FC icon
2244
Franklin Covey
FC
$234M
$103K ﹤0.01%
4,809
– –
CDZI icon
2245
Cadiz
CDZI
$292M
$102K ﹤0.01%
+10,084
New +$113K
SPRO icon
2246
Spero Therapeutics
SPRO
$68.9M
$102K ﹤0.01%
+7,571
New +$85K
BATRA icon
2247
Atlanta Braves Holdings Series A
BATRA
$3.63B
$102K ﹤0.01%
5,080
– –
CCRN
2248
DELISTED
Cross Country Healthcare
CCRN
$102K ﹤0.01%
16,495
– –
STXS icon
2249
Stereotaxis
STXS
$139M
$102K ﹤0.01%
+22,778
New +$92.2K
RNAC icon
2250
Cartesian Therapeutics
RNAC
$263M
$101K ﹤0.01%
+1,190
New +$108K
88 89
90
91 92

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.